MedTrace Logo

Clinical Trials With a Local Anesthetic Lozenge for the Treatment of Chronic Oral Pain

NCT01584947 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2016-02-19

No results posted yet for this study

Summary

The aim of the project is to do a fase two trial, where the effect of a local anesthetic lozenge will be tested in regard to oral pain, dryness of the mouth, irregularity of taste as well as investigate a potential antiinflammatory effect in patients with burning mouth syndrome, Sjögrens syndrome and lichen planus.

Conditions

Interventions

DRUG

Bupivacaine

Bupivacaine lozenge taken 3 times a day for two weeks

DRUG

Placebo

Placebo lozenge taken three times a day for two weeks

Sponsors & Collaborators

  • Oracain II Aps

    collaborator UNKNOWN

  • Hvidovre University Hospital

    lead OTHER

Principal Investigators

  • Anne Marie L Pedersen, Ph.d. · Department of Odontology, University of Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2014-01-31
Completion
2014-08-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01584947 on ClinicalTrials.gov